Skip to main content

2020 ASTRO Presentations and Posters

Friday, October 23, 2020
ASTRO title

Duke Radiation Oncology is proud to represent our Department during ASTRO 2020. Please see below for presentations and posters from our faculty and staff.

 

Oral presentations

October 24

1:15 – 2:25 p.m.
Manisha Palta, MD  •  PRO 04 - Gastrointestinal Cancer: Case Based Discussion

 

October 25

9:00 – 10:00 a.m.
Wentao Wang, MS (MPGP)  •  Fluence Map Prediction for Fast Pancreas Stereotactic Body Radiation Therapy (SBRT) Planning via Deep Learning 

9:00 – 10:00 a.m.
Chenyang Liu, MS (Duke Kunshan)  •  An Encoder-Decoder Based Deep Learning AI agent for Spatial Dose Distribution Prediction: A Study of Complex Head-and-Neck IMRT Application

9:45 a.m.
Bridget Koontz, MD  •  ASTRO Scientific Review 2020 (Speaker)

11:15 a.m.
Bridget Koontz, MD  •  PRO 08: (SA-CME) Prostate Cancer: Case Based Discussion (Speaker)

2:15 p.m.
Sua Yoo, PhD  •  Clinical Experience of the Machine Learning-Based Automated Treatment Planning Tool for Breast Radiotherapy

 

October 26

11:30 a.m – 12:30 p.m.
Manisha Palta, MD  •  Quick Pitch – Hypofractionation in GI Cancers

12:30 – 12:40 p.m.
Fang-Fang Yin, PhD  •  Applications and Quality Assurance Consideration for Lung Clinical Trials Using Radiomics

12:30 – 1:00 p.m.
Bridget Koontz, MD  •  Organizer, Women in GU Virtual Get Together at Virtual ASTRO

12:30 – 1:45 p.m.
Rachel Blitzblau, MD, PhD  •  The Impact of Neoadjuvant Therapeutics on the Surgical, Medical Oncological and Irradiation Approaches to Breast Cancer Treatment

2:13 p.m.
Junzo Chino, MD  •  Cervical Cancer Guideline

4:30 – 5:30 p.m.
Grace Kim, MD, PhD  •  Outcomes in Patients with 4-10 Brain Metastases Treated with Dose-Adapted Single-Isocenter Multitarget Stereotactic Radiosurgery: A Prospective Study

 

October 27

12:45 – 1:45 p.m.
Brad Ackerson, MD  •  Treatment of Mycosis Fungoides using a Recumbent Total Skin Electron Beam Technique: A Comparison of Dosimetric and Clinical Outcomes

12:45 p.m.
Jeremy Price, MD, PhD  •  Effective pain control with very low dose palliative radiotherapy for multiple myeloma patients with painful osseous lesions

2:00 p.m.
Jeremy Price, MD, PhD  •  Radiation Therapy and Immune Checkpoint Inhibition in Metastatic Non-Small Cell Lung Cancer: Determining Toxicity and Efficacy of Combination Treatment

 

October 28

12:00 – 1:15 p.m.
Jiahan Zhang, PhD  •  Quantifying the progression of clinical knowledge with a knowledge-based tradeoff model

1:00 p.m.
Junzo Chino, MD  •  Challenging Cases in Uterine Cancer

 

Posters  (discussion, presentations and eposters)

 

October 25,  2:15 – 3:15 p.m.

Cui, Yang, Yin, Yoo, Kim, Duan: Evaluation of Two Automated Treatment Planning Techniques for Multiple Brain Metastases Using A Single Isocenter

Qiuwen Wu and Xiaomin Liang. A Novel AP/PA Total Body Irradiation Technique Using Abutting IMRT Fields at Extended SSD

Jiahan Zhang, Chunhao Wang, Yang Sheng, Jiang Zhang, Manisha Palta, Brian Czito, Christopher Willett, Yaorong Ge, Fang-Fang Yin, Q. Jackie Wu: Simulating planners’ interactions with the treatment planning system: a reinforcement learning study for pancreas SBRT planning

 

October 25, 4:45 – 5:45 p.m.

David Carpenter, MD, MHS  •  Long-Term Experience in an Equal Access Health Care System Using Moderately Hypofractionated Radiotherapy for High Risk Prostate Cancer in a Predominately African American Population with Unfavorable Disease

Jeremy Price, MD, PhD  •  Deciphering the role of MerTK in sarcomagenesis and response to radiation and immune checkpoint therapy

 

October 26,  2:00 – 3:00 p.m.

Colin Kent, MD  •  Association of Interim FDG-PET During Chemoradiation for Anal Squamous Cell Carcinoma with Recurrence: An Updated Analysis

 

October 26, 4:40 – 5:30 p.m.

Divya Natesan, MD  •  Ipsilateral versus Bilateral Neck Radiation Therapy for Tonsillar Squamous Cell Carcinoma.

 

October 27, 2:00 – 3:00 p.m.

Andrew Fairchild, MD  •  Primary Mediastinal (Thymic) Large B-cell Lymphoma: The Working Diagnosis vs WHO Classification Criteria

 

October 27, 4:30 – 5:30 p.m.

John Kirkpatrick, MD, PhD  •  Preserving Neurocognition without Compromising Tumor Control during Whole-Brain Radiotherapy Therapy in Patients with Numerous Brain Metastases via a Novel Superoxide Dismutase Mimetic: Initial Safety Lead-In and Design of a Clinical Trial; Kirkpatrick, Floyd, et al.

 

October 28, 2:00 – 3:00 p.m.

Divya Natesan, MD  •  Does Efficacy and Toxicity Differ According to Prostate Volume in Men Treated with Moderately Hypofractionated Radiation Therapy? 

Neville Eclov, PhD  •  Challenges of the clinical machine learning implementation for the prospective System for High Intensity EvaLuation During Radiation Therapy (SHIELD-RT) study